Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00796809 · ClinicalTrials.gov registry record
Risk of Coccidioidomycosis in Patients Receiving Anti-TNF and Other Biologic Agents for an Inflammatory Arthritis
A clinical trial of Rheumatoid Arthritis and Coccidioidomycosis, sponsored by University of Arizona.
- Completed
- Registry status
- 598
- Enrollment target
- 1
- Study location
NCT00796809: Completed study of Rheumatoid Arthritis and Coccidioidomycosis, sponsored by University of Arizona.
NCT00796809 is a study of Rheumatoid Arthritis and Coccidioidomycosis that has completed, run by University of Arizona. The registered enrollment target is 598 participants, below the 4,688-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00796809, a study of Rheumatoid Arthritis and Coccidioidomycosis, has completed, sponsored by University of Arizona.
- COMPLETED
- Registry status
- 598 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of the project is to study the risk of coccidioidomycosis (valley fever) in patients receiving anti-TNF and other biologic agents for inflammatory arthritis in Tucson, Arizona.
Conditions Studied
Study Locations (1)
Arizona
- University of Arizona - Arizona Arthritis Center - Tucson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 598 participants |
| Start Date | 2007-10 |
| Est. Completion | 2008-10 |
What the finished NCT00796809 record still lists
NCT00796809 is an observational study that tracks outcomes without assigning an intervention. The registered 598 participants enrollment target is mid-sized for trials with a published cap, below the 4,688-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (87% lower).
The record links to 2 conditions, with Rheumatoid Arthritis appearing as the primary indexed condition, and to 0 interventions.
NCT00796809 reports a single indexed study location in Arizona.
Frequently Asked Questions
What is clinical trial NCT00796809 about?
NCT00796809 is a clinical study titled "Risk of Coccidioidomycosis in Patients Receiving Anti-TNF and Other Biologic Agents for an Inflammatory Arthritis". The goal of the project is to study the risk of coccidioidomycosis (valley fever) in patients receiving anti-TNF and other biologic agents for inflammatory arthritis in Tucson, Arizona.
What is the current status of trial NCT00796809?
This trial is currently completed. The enrollment target is 598 participants. The study started on 2007-10. Estimated completion is 2008-10.
What conditions does trial NCT00796809 study?
This clinical trial studies the following conditions: Rheumatoid Arthritis, Coccidioidomycosis.
Who is sponsoring clinical trial NCT00796809?
This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00796809 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Rheumatoid Arthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00796809's enrollment target sits among peer trials
598 36th of 197 higher than 162 of 197 other Rheumatoid Arthritis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Rheumatoid Arthritis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Rheumatology Diet Study
RECRUITING
-
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
RECRUITING · Phase 1
-
EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN))
RECRUITING · NA
-
Creating Health Course Study for People With Rheumatological Conditions
RECRUITING · NA
-
Physica System Total Knee Replacement Registry Study
RECRUITING · NA
-
Study of GS-0151 in Participants With Rheumatoid Arthritis
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06875973 · 599 participants · Phase 3
Pelacarsen Roll-over Extension Program
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
- NCT00209235 · 600 participants · NA
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
- NCT01473784 · 600 participants · NA
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia